ERBB3 anticorps (AA 22-369)
-
- Antigène Voir toutes ERBB3 Anticorps
- ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))
-
Épitope
- AA 22-369
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp ERBB3 est non-conjugé
-
Application
- ELISA, Immunocytochemistry (ICC)
- Fonction
- ERBB3 Antibody
- Purification
- Ascitic fluid
- Immunogène
- Purified recombinant extracellular fragment of human ERBB3 (aa22-369) fused with hIgGFc tag expressed in HEK293 cells.
- Clone
- 2F9
- Isotype
- IgG1
- Top Product
- Discover our top product ERBB3 Anticorps primaire
-
-
- Indications d'application
-
ELISA: 1/10000
ICC: 1/200 - 1/1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients." dans: Breast cancer research : BCR, Vol. 10, Issue 1, pp. R2, (2008) (PubMed).
: "Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway." dans: Cancer science, Vol. 98, Issue 9, pp. 1498-503, (2007) (PubMed).
: "
-
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients." dans: Breast cancer research : BCR, Vol. 10, Issue 1, pp. R2, (2008) (PubMed).
-
- Antigène
- ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))
- Autre désignation
- ERBB3 (ERBB3 Produits)
- Synonymes
- anticorps ErbB-3, anticorps HER3, anticorps LCCS2, anticorps MDA-BF-1, anticorps c-erbB-3, anticorps c-erbB3, anticorps erbB3-S, anticorps p180-ErbB3, anticorps p45-sErbB3, anticorps p85-sErbB3, anticorps ERBB3, anticorps C76256, anticorps Erbb-3, anticorps Erbb3r, anticorps Her3, anticorps nuc-ErbB3, anticorps erb-b2 receptor tyrosine kinase 3, anticorps v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian), anticorps ERBB3, anticorps Erbb3
- Sujet
-
Description:
ERBB3, v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian). It is a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.
Aliases: HER3, c-erbB3
- Poids moléculaire
- 148kDa
- ID gène
- 2065
- HGNC
- 2065
- UniProt
- P21860
- Pathways
- Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
-